Michael Platten

Neurology — University Medical Centre Mannheim, Germany

LeadR Profile

Michael Platten University Medical Centre Mannheim Germany
2 160 ScienceLeadR Reputation 2160
Network Map

Neurology

Subspecialties: Oncology - Immunology - Hematology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2000 - 2026

Source: PubMed

Heidelberg University (Germany)

could not re-read experiences after save", error); return null; } if (persistedEntries === null) { return null; } if (persistedEntries.length === 0 && sent.some((entry) => entry.isvisible !== false)) { console.warn(" re-read after save came back empty, keeping the edited entries"); return null; } this.state.current.experience = persistedEntries; const expected = this.yearsSignature(sent); const received = this.yearsSignature(persistedEntries.map((entry) => ({ isvisible: entry.isvisible, topresent: entry.topresent, year_start: entry.startperiod, year_stop: entry.endperiod }))); if (expected !== received) { console.error(" saved experiences were not persisted as sent", { sent: expected, received: received }); return false; } return true; }, async fetchExperiences() { const response = await $.ajax({ url: ajaxLoadUserData, type: "POST", data: { security: ajaxDataLoadUserData.security, data_to_load: "OrganizationHisto", } }); const parsedData = JSON.parse(response); if (parsedData.loaded === false || !parsedData.user_data || !Array.isArray(parsedData.user_data)) { return null; } return parsedData.user_data.map((value, index) => ({ company: value["name"], url: "", position: (value.hasOwnProperty("position") ? ( value["position"] ) : ( "" ) ), startperiod: value["year_start"], endperiod: value["year_stop"], topresent: (value.hasOwnProperty("topresent") ? ( value["topresent"] ) : ( false ) ), orgid: value["orgid"], isvisible: (value.hasOwnProperty("isvisible") ? ( value["isvisible"] ) : ( true ) ), description: "", tags: [], isOpen: false, ismain: (value.hasOwnProperty("ismain") ? ( value["ismain"] ) : ( (index === 0) ? true : false ) ) })); }, async loadDataOnMount() { this.loading = true; try { const experiences = await this.fetchExperiences(); this.loadFailed = experiences === null; if (experiences !== null) { this.state.current.experience = experiences; } } catch (error) { console.warn(" could not load experiences", error); this.loadFailed = true; } this.loading = false; } }, computed: { experience: { get() { return this.state.current.experience }, }, }, async mounted() { await this.loadDataOnMount() }, } }; })

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 586

Citations

Citations: 41 263 1st author: 57 Last author: 103 Unique author: 9


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Type I interferon drives T cell responses to amyloid beta in the central nervous system.
cells, amyloid beta-peptides, biological science disciplines, pathology, central nervous system, immunity, interferon type i, amyloid, nervous system, t-lymphocytes
Nat Commun20260
Functional segregation of HIF-1α and AhR controls NK cell responsiveness under hypoxia.
cells, killer cells, natural, hypoxia
iScience20260
Cancer neuroscience: The past, the present, and the road ahead.
neoplasms, cell biology, neurosciences, therapeutics, nervous system
Cell Top journal20260
Association of Preferred Language and Race with Perioperative Oral Midazolam Administration in Pediatric Patients: A Retrospective Cohort Study.
language, cohort studies, midazolam
J Racial Ethn Health Disparities20260
L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy and bevacizumab in newly-diagnosed glioblastoma: expansion of the phase I/II GLORIA trial.
radiotherapy, biological science disciplines, neoplasms, bevacizumab, glioblastoma, therapeutics, rna
Nat Commun20260

Clinical Studies 14

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 3

By phase:

Phase 3 6
Phase 1 4
Phase 1/Phase 2 2
Phase 2 1
Phase 4 1

By status:

Completed 8
Active not recruiting 4
Recruiting 2

By type:

Interventional 14

By Monocentric/Multicentric:

monocentric 3
multicentric2to4 0
multicentric5to9 2
multicentricup10 9

Main Topics

Ongoing Clinical Trials

2 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
A Clinical Study to Improve Brain Function and Quality of Life of Patients With Newly Diagnosed Brain Tumors (Gliomas)
NCT05331521 — radiotherapy, brain neoplasms, quality of life, glioma, bone marrow, temozolomide, brain, neoplasms, lomustine, recycling, drug therapy, chemoradiotherapy, vincristine, diagnosis, procarbazine, therapeutics, oligodendroglioma, chemotherapy
Phase 3Recruiting2021
A MultIceNTER Phase I Peptide VaCcine Trial for the Treatment of H3 Mutated Gliomas
NCT04808245 — radiotherapy, injections, skin, cells, imiquimod, glioma, vaccines, immunotherapy, vaccination, histones, glioblastoma, therapeutics, protein subunit vaccines
Phase 1Active not recruiting2023

LeadR Networks

Main global connection map